Here's the latest on UPMC's development of small antibody to fight SARS-CoV-2
October 14, 2020 at 14:38 PM EDT
The work for Ab8 began as a direct result of UPMC's increased emphasis several years ago in translational science, immunotherapy and the recruitment of a global antibody expert.